ASCO Post: Momelotinib for Symptomatic and Anemic Patients With Myelofibrosis
June 13, 2022
Dr. Ruben Mesa, Mays Cancer Center, is quoted in this article. Read More
Mays Cancer Center receives grants, continued support from American Cancer Society
June 13, 2022
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (June 13, 2022) – In late April, American Cancer Society (ACS) awarded the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, two check donations in the amounts of $480,000 for an institutional research grant and $65,000 for cancer support grants. Both checks were […]
Healio: Momelotinib superior to danzol in symptomatic and anemic myelofibrosis
June 9, 2022
Dr. Ruben Mesa, Mays Cancer Center, is quoted in this article. Read More
Mays Cancer Center has large presence at ASCO Annual Meeting
June 6, 2022
Investigators from the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer, are presenting multiple research abstracts at this week’s Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Topics and links to abstracts are below. Congratulations to all Mays Cancer Center researchers for this fine work. Impact of […]
Brian Fricke, MD, shares 6 Steps to Starting Exercise After Cancer Treatment
June 6, 2022
In honor of cancer survivor’s month, I thought I would share some tips about getting back to exercise after cancer treatment. I also would encourage anyone battling cancer to read these tips, as early research suggests that physical activity during cancer treatment may improve symptoms related to cancer and its treatment. It may also enhance recovery […]
Promising compound kills range of hard-to-treat cancers by targeting a previously undiscovered vulnerability
June 2, 2022
ERX-41, developed by UT Health San Antonio scientists, exploits a previously unrecognized weakness in breast cancer and other solid tumors. Media contact: Will Sansom, 210-567-2579, Sansom@uthscsa.edu SAN ANTONIO (June 2, 2022) – A compound, developed by a team including scientists from The University of Texas Health Science Center at San Antonio, kills a range of hard-to-treat cancer […]
